このコーナーでは、L-FABP関連の論文を、慢性腎臓病（CKD）、急性腎障害（AKI）、薬剤性腎障害（Toxicology）、薬理学（Pharmacology）、運動（Exercise）/ 熱中症（Heatstroke）、産科婦人科（Obstetrics and Gynecology）、新型コロナウイルス感染症（COVID-19）、日本語総説、ガイドラインなどに分類し、紹介いたします。 文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号（文献リストの赤色の数字）を入力の上、ご連絡ください。
文献カテゴリ
これまでの文献はこちら
関連文献の新着一覧
NEW
- 産科婦人科（Obstetrics and Gynecology）
262
Amniotic Fluid Neutrophil Gelatinase-Associated Lipocalin and L-Type Fatty Acid-Binding Protein Levels in Predicting Long-Term Prognosis in Fetal Growth Restriction andPreterm Birth: A Preliminary Study.
NEW
- 産科婦人科（Obstetrics and Gynecology）
247
Urine and serum L-type fatty acid-binding protein levels in preeclampsia: a prospective cohort study on maternal deterioration predictions.
NEW
- 産科婦人科（Obstetrics and Gynecology）
220
Evaluation of amniotic fluid neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein levels during pregnancy.
NEW
- 産科婦人科（Obstetrics and Gynecology）
207
Increased urinary albumin leakage is related to injuries of glomerular glycocalyx and podocytes, and associated with tubular dysfunction in preeclampsia.
NEW
- 産科婦人科（Obstetrics and Gynecology）
174
Amniotic Fluid L-Type Fatty Acid-Binding Protein in Predicting Fetal Condition.
NEW
- 産科婦人科（Obstetrics and Gynecology）
145
The influence of renal function by ibuprofen treatment for patent ductus arteriosus in extremely low -birth-weight infants.
NEW
- 急性腎障害（AKI）
267
Prognosis prediction by urinary liver-type fatty acid-binding protein in patients in theintensive care unit admitted from the emergency department: A single-center, historicalcohort study.
NEW
- 産科婦人科（Obstetrics and Gynecology）
95
Urinary liver-type fatty acid-binding protein change in gestational diabetes mellitus.
NEW
- 産科婦人科（Obstetrics and Gynecology）
9
Quantification of L-type fatty acid binding protein in the urine of preterm neonates.
- 急性腎障害（AKI）
266
Clinical Utility of Urinary Liver-Type Fatty Acid-Binding Protein Measured via Point-of- Care Testing in Acute Kidney Injury After Transcatheter Aortic Valve Implantation.
Nephrology (Carlton). 2026
doi: 10.1111/nep.70200.PubMed
- 慢性腎臓病（CKD）
265
Verification of the Utility of Urinary L-FABP as a Predictor of Impaired Renal Function Based on Its Relationship with Changes in Renal Function.
J Clin Med. 2026
doi: 10.3390/jcm15062243.PubMed
- 急性腎障害（AKI）
- 薬剤性腎障害（Toxicology）
264
Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin- Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial.
JMIR Res Protoc. 2026
doi: 10.2196/87907.PubMed
- 急性腎障害（AKI）
263
Comparative Prognostic Value of Four Urinary Biomarkers for Cardiovascular and Renal Outcomes After Transcatheter Aortic Valve Implantation.
- 慢性腎臓病（CKD）
262
Amniotic Fluid Neutrophil Gelatinase-Associated Lipocalin and L-Type Fatty Acid-Binding Protein Levels in Predicting Long-Term Prognosis in Fetal Growth Restriction and Preterm Birth: A Preliminary Study.
- 急性腎障害（AKI）
261
The utility of urinary liver-binding fatty acid protein levels as a promising biomarker for early detection of acute kidney injury following coronary angiography: a pre-post study at Suez Canal University Hospital.
- 急性腎障害（AKI）
260
Renoprotective effects of human L-type fatty acid-binding protein (hL-FABP) in rhabdomyolysis-induced acute kidney injury.
- 急性腎障害（AKI）
259
Clinical Utility of Liver-type Fatty Acid-binding Protein (L-fabp), and Tissue Inhibitor of Metalloproteinase-2 and Insulin-like Growth Factor-binding Protein-7 (Timp-2*igfbp-7) as Early Detector for Acute Kidney Injury in Surgical Patients After Cardiopulmonary Bypass.
- 慢性腎臓病（CKD）
- 薬理学（Pharmacology）
258
Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation.
PLoS One. 2021
doi: 10.1371/journal.pone.0248577.PubMed
doi: 10.1371/journal.pone.0248577.PubMed
- 慢性腎臓病（CKD）
- 薬理学（Pharmacology）
257
Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
Diab Vasc Dis Res. 2018
doi: 10.1177/1479164118782872. Epub 2018 Jun 20.PubMed
doi: 10.1177/1479164118782872. Epub 2018 Jun 20.PubMed
